{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:58:19Z","timestamp":1785416299876,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2018BR40"],"award-info":[{"award-number":["2018BR40"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["30801122"],"award-info":[{"award-number":["30801122"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2018ZSQN15"],"award-info":[{"award-number":["2018ZSQN15"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-018-1117-5","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T06:18:41Z","timestamp":1547187521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia"],"prefix":"10.1186","volume":"10","author":[{"given":"Tianyue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"1117_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1253\/circj.CJ-11-0552","volume":"76","author":"HM Ryu","year":"2012","unstructured":"Ryu HM, Kim JS, Ko YG, Hong MK, Jang Y, Choi DH. Comparison of clinical outcome of infrapopliteal angioplasty between Korean diabetic and non-diabetic patients with critical limb ischemia. Circ J. 2012;76:335\u201341.","journal-title":"Circ J"},{"issue":"SupplS","key":"1117_CR2","first-page":"S5","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the Management of Peripheral Arterial Disease (TASC II). J VascSurg. 2007;45(SupplS):S5\u201367.","journal-title":"J VascSurg"},{"key":"1117_CR3","first-page":"958","volume":"63","author":"JJ Siracuse","year":"2016","unstructured":"Siracuse JJ, Menard MT, Eslami MH, et al. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative. J VascSurg. 2016;63:958\u201365 e1.","journal-title":"J VascSurg"},{"key":"1117_CR4","first-page":"445","volume":"53","author":"H Lawall","year":"2011","unstructured":"Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J VascSurg. 2011;53:445\u201353.","journal-title":"J VascSurg"},{"key":"1117_CR5","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1253\/circj.CJ-17-1220","volume":"82","author":"T Horie","year":"2018","unstructured":"Horie T, Yamazaki S, Hanada S, et al. Outcome from a randomized controlled clinical trial- improvement of peripheral arterial disease by granulocyte Colony-stimulating factor-mobilized autologous peripheral-blood-mononuclear cell transplantation (IMPACT). Circ J. 2018;82:2165\u201374.","journal-title":"Circ J"},{"key":"1117_CR6","doi-asserted-by":"crossref","unstructured":"Pignon B, Sevestre MA, Kanagaratnam L, et al. Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia- results of a randomized, double-blind, placebo-controlled trial. Circ J. 2017;81:1713\u201320.","DOI":"10.1253\/circj.CJ-17-0045"},{"key":"1117_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"M Teraa","year":"2015","unstructured":"Teraa M, Sprengers RW, Schutgens RE, et al. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled rejuvenating endothelial progenitor cells via transcutaneous intra-arterial supplementation (JUVENTAS) trial. Circulation. 2015;131:851\u201360.","journal-title":"Circulation"},{"key":"1117_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","volume":"58","author":"Z Dong","year":"2013","unstructured":"Dong Z, Chen B, Fu W, et al. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia. J Vasc Surg. 2013;58:404\u201311 e3.","journal-title":"J Vasc Surg"},{"key":"1117_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/dmrr.2399","volume":"29","author":"M Dubsky","year":"2013","unstructured":"Dubsky M, Jirkovska A, Bem R, et al. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Diabetes Metab Res Rev. 2013;29:369\u201376.","journal-title":"Diabetes Metab Res Rev"},{"key":"1117_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","volume":"5","author":"DW Losordo","year":"2012","unstructured":"Losordo DW, Kibbe MR, Mendelsohn F, et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv. 2012;5:821\u201330.","journal-title":"Circ Cardiovasc Interv"},{"key":"1117_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","volume":"4","author":"DH Walter","year":"2011","unstructured":"Walter DH, Krankenberg H, Balzer JO, et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv. 2011;4:26\u201337.","journal-title":"Circ Cardiovasc Interv"},{"key":"1117_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3727\/096368910X514170","volume":"19","author":"V Prochazka","year":"2010","unstructured":"Prochazka V, Gumulec J, Jaluvka F, et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant. 2010;19:1413\u201324.","journal-title":"Cell Transplant"},{"key":"1117_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427\u201335.","journal-title":"Lancet"},{"key":"1117_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jcyt.2013.05.017","volume":"15","author":"GV Szabo","year":"2013","unstructured":"Szabo GV, Kovesd Z, Cserepes J, Daroczy J, Belkin M, Acsady G. Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up. Cytotherapy. 2013;15:1245\u201352.","journal-title":"Cytotherapy"},{"key":"1117_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","volume":"26","author":"A Ozturk","year":"2012","unstructured":"Ozturk A, Kucukardali Y, Tangi F, et al. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia. J Diabetes Complicat. 2012;26:29\u201333.","journal-title":"J Diabetes Complicat"},{"key":"1117_CR16","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1253\/circj.CJ-17-0510","volume":"82","author":"K Kondo","year":"2018","unstructured":"Kondo K, Yanishi K, Hayashida R, et al. Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan. Circ J. 2018;82:1168\u201378.","journal-title":"Circ J"},{"key":"1117_CR17","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1161\/CIRCULATIONAHA.108.837039","volume":"120","author":"TS Li","year":"2009","unstructured":"Li TS, Kubo M, Ueda K, et al. Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients. Circulation. 2009;120:S255\u201361.","journal-title":"Circulation"},{"key":"1117_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.105.541268","volume":"113","author":"H Iwasaki","year":"2006","unstructured":"Iwasaki H, Kawamoto A, Ishikawa M, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113:1311\u201325.","journal-title":"Circulation"},{"key":"1117_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1358863X17752556","volume":"23","author":"T Pan","year":"2018","unstructured":"Pan T, Wei Z, Fang Y, Dong Z, Fu W. Therapeutic efficacy of CD34(+) cell-involved mononuclear cell therapy for no-option critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Vasc Med. 2018;23:219\u201331.","journal-title":"Vasc Med"},{"key":"1117_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato M, Monami M, Fadini GP. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res. 2017;120:1326\u201340.","journal-title":"Circ Res"},{"key":"1117_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13287-016-0379-z","volume":"7","author":"J Madaric","year":"2016","unstructured":"Madaric J, Klepanec A, Valachovicova M, et al. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia. Stem Cell Res Ther. 2016;7:116.","journal-title":"Stem Cell Res Ther"},{"key":"1117_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1253\/circj.CJ-11-0605","volume":"76","author":"M Kubo","year":"2012","unstructured":"Kubo M, Li TS, Kurazumi H, et al. Hypoxic preconditioning enhances angiogenic potential of bone marrow cells with aging-related functional impairment. Circ J. 2012;76:986\u201394.","journal-title":"Circ J"},{"key":"1117_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jtcvs.2009.07.053","volume":"139","author":"TS Li","year":"2010","unstructured":"Li TS, Kubo M, Ueda K, Murakami M, Mikamo A, Hamano K. Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure. J Thorac Cardiovasc Surg. 2010;139:459\u201365.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1117_CR24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","volume":"102","author":"S Dimmeler","year":"2008","unstructured":"Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res. 2008;102:1319\u201330.","journal-title":"Circ Res"},{"key":"1117_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00380-017-0968-5","volume":"32","author":"N Aoyama","year":"2017","unstructured":"Aoyama N, Nishinari M, Ohtani S, et al. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis. Heart Vessel. 2017;32:1099\u2013108.","journal-title":"Heart Vessel"},{"key":"1117_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.12968\/jowc.2010.19.5.48048","volume":"19","author":"C Ruangsetakit","year":"2010","unstructured":"Ruangsetakit C, Chinsakchai K, Mahawongkajit P, Wongwanit C, Mutirangura P. Transcutaneous oxygen tension: a useful predictor of ulcer healing in critical limb ischaemia. J Wound Care. 2010;19:202\u20136.","journal-title":"J Wound Care"},{"key":"1117_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1373\/clinchem.2016.263798","volume":"63","author":"S Hazarika","year":"2017","unstructured":"Hazarika S, Annex BH. Biomarkers and genetics in peripheral artery disease. Clin Chem. 2017;63:236\u201344.","journal-title":"Clin Chem"},{"key":"1117_CR28","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1161\/01.CIR.0000127577.63323.24","volume":"109","author":"S Verma","year":"2004","unstructured":"Verma S, Kuliszewski MA, Li SH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004;109:2058\u201367.","journal-title":"Circulation"},{"key":"1117_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/0003319717739720","volume":"69","author":"P Altes","year":"2018","unstructured":"Altes P, Perez P, Esteban C, et al. Raised fibrinogen levels and outcome in outpatients with peripheral artery disease. Angiology. 2018;69:507\u201312.","journal-title":"Angiology"},{"key":"1117_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jvs.2014.02.013","volume":"60","author":"SM Grenon","year":"2014","unstructured":"Grenon SM, Cohen BE, Smolderen K, Vittinghoff E, Whooley MA, Hiramoto J. Peripheral arterial disease, gender, and depression in the heart and soul study. J Vasc Surg. 2014;60:396\u2013403.","journal-title":"J Vasc Surg"},{"key":"1117_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI9087","volume":"106","author":"GC Schatteman","year":"2000","unstructured":"Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest. 2000;106:571\u20138.","journal-title":"J Clin Invest"},{"key":"1117_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/sctm.17-0043","volume":"7","author":"R Tanaka","year":"2018","unstructured":"Tanaka R, Masuda H, Fujimura S, et al. Quality-quantity control culture enhances Vasculogenesis and wound healing efficacy of human diabetic peripheral blood CD34+ cells. Stem Cells Transl Med. 2018;7:428\u201338.","journal-title":"Stem Cells Transl Med"},{"key":"1117_CR33","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/stem.207","volume":"27","author":"A Kawamoto","year":"2009","unstructured":"Kawamoto A, Katayama M, Handa N, et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells. 2009;27:2857\u201364.","journal-title":"Stem Cells"},{"key":"1117_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ebiom.2018.08.038","volume":"35","author":"Z Dong","year":"2018","unstructured":"Dong Z, Pan T, Fang Y, et al. Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-month results of a prospective randomised single-blinded non-inferiority trial. EBioMedicine. 2018;35:46\u201357.","journal-title":"EBioMedicine"},{"key":"1117_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jcyt.2014.03.007","volume":"16","author":"L Sun","year":"2014","unstructured":"Sun L, Wu L, Qiao Z, et al. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia. Cytotherapy. 2014;16:1110\u20136.","journal-title":"Cytotherapy"},{"key":"1117_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2009.07.050","volume":"208","author":"T Horie","year":"2010","unstructured":"Horie T, Onodera R, Akamastu M, et al. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis. 2010;208:461\u20136.","journal-title":"Atherosclerosis"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1117-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1117-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1117-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:08:37Z","timestamp":1578683317000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1117-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1117-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study design was approved by the Ethics Committee of Zhongshan Hospital, Fudan University, Shanghai, China. All included patients were informed about the nature of the study and gave their written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed a consent form for their data to be used for research or publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"15"}}